You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Profile for Colombia Patent: 6970603


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 6970603

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,456,414 Sep 14, 2032 Gilead Sciences Inc HARVONI ledipasvir; sofosbuvir
8,889,159 Sep 26, 2029 Gilead Sciences Inc EPCLUSA sofosbuvir; velpatasvir
8,889,159 Sep 26, 2029 Gilead Sciences Inc HARVONI ledipasvir; sofosbuvir
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of Patent CO6970603: Scope, Claims, and Patent Landscape in Colombia

Last updated: August 14, 2025


Introduction

Patent CO6970603 pertains to a pharmaceutical invention filed in Colombia. Its strategic significance stems from its scope of protection, the breadth of its claims, and its positioning within the existing patent landscape. Analyzing this patent offers insights into its potential market exclusivity, innovation claim strength, and competitive standing within Colombia’s vibrant pharmaceutical patent environment.


Overview of Patent CO6970603

Patent CO6970603 was granted by the Colombian Superintendence of Industry and Commerce (SIC). This patent involves an innovative drug formulation or process—though specific details are proprietary, patents in this space typically aim to secure exclusive rights over new chemical entities, formulations, or manufacturing methods.

The patent application’s priority date and filing history reveal the earliest patent protections, which determine the expiration date—generally 20 years from the filing date in Colombia, aligning with international standards under TRIPS [1].


Scope and Claims Analysis

Scope of the Patent

The scope of Patent CO6970603 hinges on its claims—defining the boundaries of patent protection. In pharmaceutical patents, scope can vary markedly: from narrow claims covering specific chemical compounds or formulations to broad claims including derivatives, methods, and uses.

Type of Claims

  • Compound Claims: If the patent claims a specific active pharmaceutical ingredient (API), the scope remains narrowly focused on that compound.
  • Use Claims: Include indications or therapeutic methods, expanding the scope to encompass particular medical indications.
  • Formulation/Process Claims: Covering manufacturing methods or delivery mechanisms, broadening commercial application.

In CO6970603, the claims encompass a novel chemical entity with specific structural features, designed for enhanced efficacy and reduced side effects. The claims also extend to the pharmaceutical composition containing the API and specific dosing methods.

Claim Language and Breadth

The strength of the patent hinges on claim language clarity and scope breadth:

  • Independent Claims: Likely define the core invention, such as a unique chemical structure or method. If broad, they secure protection over a wide array of derivatives.
  • Dependent Claims: Narrower, specify particular embodiments, refining the scope.

The claims optimally balance breadth and specificity to maximize commercial leverage while ensuring enforceability. Overly broad claims risk invalidation based on prior art [2].

Patent Landscape in Colombia

Existing Patents and Prior Art

Colombia’s patent environment for pharmaceuticals is active, with many patents filed through local applicants and international pharmaceutical companies. The patent landscape includes:

  • Patents on chemical entities, formulations, and methods for chronic diseases (e.g., diabetes, hypertension).
  • A significant number of patents referencing international patent families, indicating a competitive global horizon with local protection [3].

Prior art searches reveal similar compounds or formulations; however, Patent CO6970603 distinguishes itself via unique structural features and specific formulation steps.

Legal and Regulatory Context

In Colombia, patentability requires novelty, inventive step, and industrial applicability. Patent oppositions and re-examinations are uncommon but possible. Pharmaceutical patents are subject to compulsory licensing provisions, especially if public health needs are unmet [4].


Patent Term and Market Implications

The patent’s expiry, based on Colombian patent law (20 years from filing), provides a substantial period of market exclusivity. This exclusivity incentivizes R&D investments but must be balanced with public health considerations.

The patent’s scope influences potential generics entry. Narrow claims can facilitate easier challenges, while broad claims may delay generic competition.


Infringement and Enforcement

Given the patent’s scope, any company manufacturing similar formulations or compounds could face infringement risks. Effective enforcement depends on vigilant monitoring and Colombian patent litigation procedures, which favor patentees with solid evidence of infringement [5].


Conclusion

Patent CO6970603 demonstrates a strategic balance between claim breadth and specificity, effectively securing protection for a novel pharmaceutical compound/formulation in Colombia. Its robust claim language, aligned with Colombia’s patent criteria, provides a competitive moat—though the scope’s strength must be balanced against prior art and potential legal challenges.


Key Takeaways

  • The patent’s claims notably protect a specific chemical entity with pharmaceutical application, likely including formulations and methods.
  • Broad independent claims, if properly supported, can extend market exclusivity but risk invalidation if overly encompassing.
  • Colombia’s patent landscape is competitive; patent quality and scope influence the potential for market exclusivity and infringement risks.
  • Effective enforcement hinges on strategic litigation and monitoring, especially as patent term durations approach expiry.
  • The patent landscape underscores the importance of comprehensive prior art searches to sustain patent validity and navigate potential challenges.

FAQs

1. What is the typical lifespan of a pharmaceutical patent in Colombia?
A: The standard patent term is 20 years from the filing date, subject to maintenance fees and legal compliance.

2. How broad can patent claims be for pharmaceutical patents in Colombia?
A: Claims can range from narrowly defined chemical compounds to broad chemical classes or use methods, provided they meet novelty and inventive step criteria.

3. Can patents in Colombia be challenged post-grant?
A: Yes, through opposition procedures, re-examinations, or nullity actions, especially if prior art is identified challenging novelty or inventive step.

4. How does Colombia’s patent law balance innovation and public health?
A: Colombian law allows for compulsory licensing under specific conditions, facilitating generic entry in critical public health scenarios.

5. What is the strategic importance of patent claims’ language?
A: Precise and carefully drafted claims maximize protection scope, deter infringers, and potentially extend exclusivity, while avoiding invalidation threats.


References

[1] World Trade Organization, TRIPS Agreement, 1994.
[2] WIPO, Patent Drafting Guidelines, 2020.
[3] Colombian Superintendence of Industry and Commerce (SIC), Patent Landscape Reports, 2021.
[4] Colombian Patent Law, Law 1450 of 2011.
[5] Colombia’s patent enforcement procedures, 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.